Stents or bypass surgery more effective for stable patients with high-risk cardiac anatomy
(University of Alberta Faculty of Medicine& Dentistry) A study by University of Alberta cardiologists at the Canadian VIGOUR Centre shows that a particular group of patients with stable ischemic heart disease have better outcomes with percutaneous coronary intervention (also called angioplasty with stent) or coronary artery bypass surgery and medication, versus conservative management with medication alone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 18, 2021 Category: International Medicine & Public Health Source Type: news

Primary PCI Use Down for Cancer Patients With STEMI
WEDNESDAY, Feb. 17, 2021 -- Patients with active cancer who have ST-elevation myocardial infarction (STEMI) receive primary percutaneous coronary intervention (pPCI) less often, but they have significantly lower rates of in-hospital all-cause... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2021 Category: Pharmaceuticals Source Type: news

When Heart Attack Strikes, Cancer Patients Often Miss Out on Lifesaving Treatment
FRIDAY, Feb. 5, 2021 -- Too few cancer patients who have a heart attack are receiving emergency angioplasties that could save their lives, a new study finds. " This is an important study, which underscores the broader issue in cardio-oncology of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 5, 2021 Category: General Medicine Source Type: news

Cancer patients not receiving life-saving heart attack treatment
(European Society of Cardiology) Emergency heart attack treatment is effective in patients with cancer, yet many do not receive it. That's the finding of a study published on World Cancer Day in European Heart Journal - Acute Cardiovascular Care, a journal of the European Society of Cardiology (ESC).1 This was the first study to compare the rates of primary percutaneous coronary intervention (PCI) in heart attack patients with and without cancer, and to examine the comparative effectiveness and safety of treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2021 Category: Cancer & Oncology Source Type: news

What Is Renal Artery Angioplasty?
Title: What Is Renal Artery Angioplasty?Category: Procedures and TestsCreated: 1/29/2021 12:00:00 AMLast Editorial Review: 1/29/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 29, 2021 Category: Cardiology Source Type: news

Bengaluru doctor with double kidney transplant takes jab, backs it
Dr AP Nirmal Raj pointed out he took the Covid vaccine on January 17. “I’m taking anti-diabetic, cholesterol drugs and have undergone angioplasty earlier. People with comorbidities must not fear the vaccine,” he said. (Source: The Economic Times)
Source: The Economic Times - January 24, 2021 Category: Consumer Health News Source Type: news

Time to Angioplasty Is Crucial for Better Heart Attack Outcomes
Title: Time to Angioplasty Is Crucial for Better Heart Attack OutcomesCategory: Health NewsCreated: 1/14/2021 12:00:00 AMLast Editorial Review: 1/15/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 15, 2021 Category: Cardiology Source Type: news

Time to Angioplasty Is Crucial for Better Heart Attack Outcomes
  THURSDAY, Jan. 14, 2021 -- When a heart attack begins, the time it takes until the blockage in a coronary artery is cleared is critical in preventing further damage to the heart, a new study warns. The amount of damage is directly related... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 14, 2021 Category: General Medicine Source Type: news

Symptom-to-Balloon Time Linked to Infarct Size in STEMI
THURSDAY, Jan. 14, 2021 -- For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI), symptom-to-balloon time (SBT), but not door-to-balloon time (DBT), is associated with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2021 Category: Pharmaceuticals Source Type: news

What Is the Difference Between Angiogram and Angioplasty?
Title: What Is the Difference Between Angiogram and Angioplasty?Category: Diseases and ConditionsCreated: 1/12/2021 12:00:00 AMLast Editorial Review: 1/12/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 12, 2021 Category: Cardiology Source Type: news

Physician-Level PCI Mortality Data May Be Misleading Physician-Level PCI Mortality Data May Be Misleading
Percutaneous coronary intervention mortality data do not adequately reflect the quality of care delivered by cardiologists who perform this procedure at multiple centers, researchers report.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 4, 2021 Category: Intensive Care Tags: Cardiology News Source Type: news

Boston Scientific Withdraws Lotus Edge ™ from Market
Originally designed as a unique aortic valve system that could be repositioned and retrieved, the Lotus ™ Valve System is now also recalled. On Tuesday, Boston Scientific announced "global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system." (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - November 21, 2020 Category: Cardiology Source Type: news

Clopidogrel Bests Ticagrelor for Elective PCI Clopidogrel Bests Ticagrelor for Elective PCI
Ticagrelor failed to unseat clopidogrel as the guideline-recommended P2Y12 inhibitor of choice in patients undergoing elective percutaneous coronary intervention for stable CAD in the randomized ALPHEUS trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Marijuana Raises Post-Op Dangers After Heart Attack
Marijuana smokers are more likely to suffer complications like excess bleeding or stroke if they undergo angioplasty to reopen clogged arteries, a University of Michigan-led study found. (Source: WebMD Health)
Source: WebMD Health - November 10, 2020 Category: Consumer Health News Source Type: news

IN.PACT BTK: Step in the Right Direction for DCB in Below-Knee CLI IN.PACT BTK: Step in the Right Direction for DCB in Below-Knee CLI
The phase 2 study showed late lumen loss comparable to or better than angioplasty, with no safety signal in a space primed for new treatments.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 20, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Results from the TARGET FFR study reported at TCT Connect
(Cardiovascular Research Foundation) Results from the randomized controlled TARGET FFR trial show that while a physiology-guided percutaneous coronary intervention (PCI) optimization strategy did not achieve a significant increase in the proportion of patients with final FFR ?0.90, it reduced the proportion of patients with a residual FFR ?0.80 following PCI. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2020 Category: International Medicine & Public Health Source Type: news

DISRUPT CAD III Meets all Endpoints in U.S. Pivotal Study for Coronary Intravascular Lithotripsy
The Shockwave Coronary IntraVascular Lithotripsy (IVL) System has been available in Europe for more than 2 years, but to receive U.S. approval, it needed to show safety and efficacy in a trial specifically designed to meet FDA requirements. Today the 30-day results of the DISRUPT CAD III were presented by Dr. Dean Kereiakes at TCTConnect, the online virtual version of the annual Transcatheter Cardiovascular Therapeutics meeting, and the device met all endpoints, moving it closer to approval for the U.S. market. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 15, 2020 Category: Cardiology Source Type: news

Medtronic Resolute Onyx ™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients
Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy (DAPT) labeling with an expanded indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx ™ DES. The Resolute Onyx DES is the first-and-only DES in the U.S. that has been proven safe and effective utilizing a one-month regimen of DAPT – the combination of aspirin and an anti-clotting medication – following a percutaneous coronary intervention (PCI) in patients at high bleeding risk . (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 1, 2020 Category: Cardiology Source Type: news

CYP2C19 Genotyping May Aid Antiplatelet Prescribing
WEDNESDAY, Sept. 9, 2020 -- Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention (PCI), according to a study published in the Aug. 25 issue of the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 9, 2020 Category: Pharmaceuticals Source Type: news

International registries show PCI rates increased in Japan, US
(American College of Cardiology) Japan and the US have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in the Journal of the American College of Cardiology. Since adoption of large-scale PCI trial results vary internationally, the study sought to analyze large national registries in both countries to illuminate international variation in PCI practice as a foundation for further quality improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction, Heart
Study (n=34,127) found decline by 43% in the number of PCI procedures for STEMI in April 2020 vs the average between 2017 and 2019, but the in-hospital mortality rate was not higher during the lockdown (3.5% vs 4.8% before the lockdown). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 3, 2020 Category: Consumer Health News Source Type: news

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease
SINGAPORE, Aug. 27, 2020 -- (Healthcare Sales & Marketing Network) -- Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the FUTURE BTK trial (Randomized Controlled Trial of Fi... Devices, Interventional Concept Medical, critical limb ischemia, angioplasty, MagicTouch PTA, sirolimus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 27, 2020 Category: Pharmaceuticals Source Type: news

Genetic testing cut adverse events in heart patients
Personalized genetic testing led to a 34% decrease in the number of patients...Read more on AuntMinnie.comRelated Reading: USPSTF advises against carotid artery stenosis screening Abbott recalls 2 coronary angioplasty catheters FDA offers guidance on angioplasty and specialty catheters USPSTF opens review of carotid stenosis screening Coronary CTA beats stress test for changing lifestyles (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 27, 2020 Category: Radiology Source Type: news

Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy
ROCHESTER, Minn. ? Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement? nonsurgical procedures to improve blood flow to the heart ? are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - August 24, 2020 Category: Hospital Management Source Type: news

What Are the Main Acyanotic Congenital Heart Diseases?
Discussion Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here. Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also. Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Black Patients Fare Worse After Angioplasty
Even after undergoing the artery-clearing procedure angioplasty, Black patients with heart disease are more likely than whites to suffer a heart attack or die within the next several years. (Source: WebMD Health)
Source: WebMD Health - July 6, 2020 Category: Consumer Health News Source Type: news

Black Patients Fare Worse After Angioplasty
MONDAY, July 6, 2020 -- Even after undergoing the artery-clearing procedure angioplasty, Black patients with heart disease are more likely than whites to suffer a heart attack or die within the next several years. That's the conclusion of a new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 6, 2020 Category: General Medicine Source Type: news

Black patients have higher rates of death after PCI
(American College of Cardiology) Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major adverse outcomes, including death, compared to white patients, according to a study published today in JACC: Cardiovascular Interventions. The study underscores the high rates of cardiovascular disease and risk factors in minorities and continued need for further research on race-based outcomes after cardiovascular procedures, including PCI, to understand and alleviate these differences. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 6, 2020 Category: International Medicine & Public Health Source Type: news

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
NYON, Switzerland, June 30, 2020 -- (Healthcare Sales & Marketing Network) -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. ... Devices, Interventional, Cardiology, Regulatory MedAlliance, SELUTION SLR, Sirolimus, Drug Eluting Balloon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 30, 2020 Category: Pharmaceuticals Source Type: news

New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages
-- Using optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI), physicians were able to select the right size stents and place them with greater precision (Source: Abbott.com)
Source: Abbott.com - June 26, 2020 Category: Pharmaceuticals Source Type: news

ABRE Study Meets Primary Safety and Effectiveness Endpoints
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre ™ venous self-expanding stent system in subjects with iliofemoral venous outflow obstruction. The study met the primary safety and effectiveness endpoints, and the data were presented today virtually via the 2020 Charing Cross Symposium. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - June 17, 2020 Category: Cardiology Source Type: news

Medtronic Expands Indications for the Resolute Onyx DES in Europe
Medtronic has scored CE mark for a unique indication for the Resolute Onyx drug-eluting stent. The Dublin-based company said the approval was for a DAPT indication for high bleeding risk (HBR) patients. The firm said for HBR patients whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and anti-clotting medication), this new, indication allows physicians to recommend a shorter, one-month regimen of DAPT, following a percutaneous coronary intervention (PCI) with Resolute Onyx. The indication is based on results from the Onyx ONE Global Study, a prospective, randomized, one-month DAPT...
Source: MDDI - June 8, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Regulatory and Compliance Cardiovascular Source Type: news

Abiomed Granted IDE to Evaluate ‘World’s Smallest Heart Pump’
Abiomed said it has received approval for an IDE to start an early feasibility study of what it is calling the “world’s smallest heart pump.”   The Danvers, MA-based company said the first-in-human trial will look at the 9 French Impella ECP heart pump in high-risk percutaneous coronary intervention (PCI) patients.   The primary endpoint of the study is successful delivery, initiation, and maintenance of adequate hemodynamic support and a composite rate of major device-related adverse events during high-risk PCI.   The stu...
Source: MDDI - June 6, 2020 Category: Medical Devices Tags: Cardiovascular Regulatory and Compliance Source Type: news

FDA Clears Innovative Angioplasty Scoring and Cutting Platform
New metal-alloy sheath converts angioplasty balloons into scoring and cutting systems PARK CITY, Utah, June 4, 2020 -- (Healthcare Sales & Marketing Network) -- Transit Scientific announced the FDA cleared the XO Score® Percutaneous Transluminal An... Devices, Interventional, FDA Transit Scientific, XO Score, Scoring Sheath, Angioplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2020 Category: Pharmaceuticals Source Type: news

Two paths better than one for treating patients with heart stents
(University of Alberta Faculty of Medicine& Dentistry) Pairing a blood-thinning drug with aspirin daily for patients who have an angioplasty with a stent can contribute to better health outcomes, including lower risk of death, than aspirin alone, according to a recent study by cardiologists at the University of Alberta and Mazankowski Alberta Heart Institute. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2020 Category: International Medicine & Public Health Source Type: news

Primary PCI Remains Standard of Care for STEMI During COVID-19
WEDNESDAY, April 29, 2020 -- Primary percutaneous coronary intervention (PCI) remains the standard of care for patients with ST-elevation myocardial infarction (STEMI) during the COVID-19 pandemic, according to a consensus statement published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 29, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 Business Updates Provide Some Clarity
The unknowns still outnumber the knowns, but recent business updates provide some clarity around how the medical device industry is fairing during the COVID-19 pandemic. First and foremost, it is clear that companies are hurting in the areas of elective procedures, which are being deferred. But there may be some silver linings hidden amongst the bad news. Needham & Co. medtech analyst Mike Matson estimates that medical device sales across the industry will continue to drop by an average of 40% to 50% until the economy begins to reopen and hospitals start to resume elective procedures. Matson's e...
Source: MDDI - April 10, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

Cardiac Arrest Deaths at Home in New York City Have Increased By a Startling 800%
There's been a 50% or more drop in the number of people receiving emergency treatment for heart attacks in many hospitals. Physicians have been speculating why this might be. Now frightening numbers from New York City's overwhelmed emergency medical system may provide part of the answer: hundreds of people a day have been dying of cardiac arrest in their homes, an eight-fold increase over the same period last year. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - April 8, 2020 Category: Cardiology Source Type: news

CABG Tied to Lower Death Rate in MI Complicated by Cardiogenic Shock CABG Tied to Lower Death Rate in MI Complicated by Cardiogenic Shock
Coronary-artery-bypass grafting (CABG) is associated with lower in-hospital mortality in myocardial infarction (MI) complicated by cardiogenic shock, compared with percutaneous coronary intervention (PCI), according to a database study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 7, 2020 Category: Surgery Tags: Cardiology News Source Type: news

Doctors Say: Don't Sit Out a Heart Attack at Home
Since the onset of the novel coronavirus COVID-19, hospital emergency departments have seen a precipitous drop in the number of heart attack patients presenting for treatment. The big question is why? Are there really less heart attacks occurring, or are patients staying home, afraid to come to the hospital for fear of contracting the virus? There's good reason to believe that the latter may be the case, and the implications are extremely troubling. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - April 7, 2020 Category: Cardiology Source Type: news

Shockwave Completes Enrollment in Pivotal Study for Coronary Intravascular Lithotripsy
Shockwave Medical, Inc. (NASDAQ: SWAV) announced today that the company has completed enrollment in the pivotal U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study – DISRUPT CAD III – for the use of IVL in heavily calcified coronary arteries. The investigational Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, which has been granted Breakthrough Device Designation by the FDA, is an innovative therapy designed to fracture problematic calciu m using sonic pressure waves in order to facilitate stent delivery, deployment and optimal expansion. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - April 6, 2020 Category: Cardiology Source Type: news

TWILIGHT Benefits of Dropping Aspirin Hold Up in Diabetes TWILIGHT Benefits of Dropping Aspirin Hold Up in Diabetes
Treatment with ticagrelor alone shows no increase in bleeding, MI, or stroke after percutaneous coronary intervention in the TWILIGHT trial subanalysis.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 1, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Genetic testing for antiplatelet therapy post-PCI misses cut in cardiovascular events
(American College of Cardiology) An international clinical trial that used genetic testing to guide which antiplatelet medication was given to patients following percutaneous coronary intervention (PCI) did not meet its stated goal for cutting in half the incidence of serious adverse cardiovascular events, such as heart attack and stroke, in the year following the procedure, according to study results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 30, 2020 Category: Biology Source Type: news

Location of Coronary-artery Lesion Not Tied to Stenting Outcome Location of Coronary-artery Lesion Not Tied to Stenting Outcome
The outcomes of percutaneous coronary intervention (PCI) with new-generation drug-eluting stents (DES) in patients with proximal left anterior descending (P-LAD) coronary-artery lesions appear similar to those seen in patients with lesions in other segments, according to data from three clinical trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news

CTO PCI Linked to Worse Outcomes in Patients With Prior CABG CTO PCI Linked to Worse Outcomes in Patients With Prior CABG
Observational data show less technical success and worse outcomes with angioplasty of chronic total occlusions after bypass surgery. Such procedures should be limited to expert centers, researchers say.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Philips Ramps Up Production of Critical Health Technology Products in Response to COVID-19 Pandemic
Philips is ramping up the production of hospital ventilators and plans to double production within the next eight weeks and achieve a four-fold increase by the third quarter of 2020. The company is mobilizing its global supplier network to step up support and production in this extraordinary situation. Philips has a global manufacturing footprint with final assembly sites in North America, Europe and Asia, and, equally important, a global network of certified materials and component suppliers. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 23, 2020 Category: Cardiology Source Type: news

Medtronic Has Ramped Up Ventilator Production
Medtronic, manufacturer of the Puritan Bennett line of ventilators, reports that they have already increased their production by 40% and are "on track" to achieve twice their normal output. Manufactured in Galway, Ireland, Medtronic's workforce numbers 250. The company is doubling that, bringing in new people and transferring staff from other Medtronic sites, and reconfiguring its plant to operate 24/7. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 19, 2020 Category: Cardiology Source Type: news

Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
MONDAY, March 16, 2020 -- For patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy is associated with a reduced risk for bleeding compared with triple therapy, according to research published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2020 Category: Pharmaceuticals Source Type: news

Cracking (the Code of) CAC to Win the Last Battle of PCI Cracking (the Code of) CAC to Win the Last Battle of PCI
A new study elucidates the underlying mechanism for an increased risk when treating calcified lesions during percutaneous coronary intervention with newer generation drug-eluting stents.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 6, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

2003 to 2016 Saw Changes in Characteristics of PCI, CABG Patients
MONDAY, March 2, 2020 -- Between 2003 and 2016, there were decreases in in-hospital mortality after coronary artery bypass grafting (CABG) but not after percutaneous coronary intervention (PCI), according to a study published online Feb. 14 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 2, 2020 Category: Pharmaceuticals Source Type: news